Division of Pediatric Hematology-Oncology, University of Alabama at Birmingham, Birmingham, AL.
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL.
JCO Oncol Pract. 2024 Apr;20(4):491-502. doi: 10.1200/OP.23.00328. Epub 2024 Jan 22.
Individuals diagnosed with cancer between 15 and 39 years (adolescent and young adult [AYA]) face unique vulnerability. Detail is lacking about care delivery for these patients, especially those with ALL. We address these knowledge gaps by describing AYA ALL care delivery details at National Cancer Institute Community Oncology Research Program (NCORP) (sub)affiliates by model of care.
Participating institutions treated at least one AYA with ALL from 2012 to 2016. Study-specific criteria were used to determine the number of unique clinical facilities (CFs) per NCORP and their model of care (adult/internal medicine [IM], pediatric, mixed [both]). Surveys completed by NCORPs for each CF by model of care captured size, resources, services, and communication.
Among 84 participating CFs (adult/IM, n=47; pediatric, n=15; mixed, n=24), 34% treated 5-10 AYAs with ALL annually; adult/IM CFs more often treated <5 (adult/IM, 60%; pediatric, 40%; mixed, 29%). Referral decisions were commonly driven by an age/diagnosis combination (58%), with frequent ALL-specific age minimums (87%) or maximums (80%). Medical, navigational, and social work services were similar across models while psychology was available at more pediatric CFs (pediatric, 80%; adult/IM, 40%; mixed, 46%-54%). More pediatric or mixed CFs reported oncologists interacting with pediatric/adult counterparts via tumor boards (pediatric, 93%; adult/IM, 26%; mixed, 96%) or initiating contact (pediatric, 100%; adult/IM, 77%; mixed 96%); more pediatric CFs reported an affiliated counterpart (pediatric, 53%; adult, 19%). Most CFs reported no AYA-specific resources (79%) or meetings (83%-98%).
System-level aspects of AYA ALL care delivery have not been examined previously. At NCORPs, these characteristics differ by models of care. Additional work is ongoing to investigate the impact of these facility-level factors on guideline-concordant care in this population. Together, these findings can inform a system-level intervention for diverse practice settings.
15 至 39 岁(青少年和年轻成人 [AYA])之间被诊断患有癌症的个体面临着独特的脆弱性。有关这些患者,尤其是 ALL 患者的护理服务的详细信息尚不清楚。我们通过描述国家癌症研究所社区肿瘤学研究计划(NCORP)(附属)机构中按护理模式提供的 AYA ALL 护理服务细节来解决这些知识空白。
参与机构在 2012 年至 2016 年间至少治疗了一名 AYA ALL 患者。每个 NCORP 针对每个 CF 按护理模式完成的研究特定标准用于确定独特的临床设施(CF)数量及其护理模式(成人/内科 [IM]、儿科、混合 [两者])。成人/IM、儿科、混合 CF 分别为 47、15、24 个。成人/IM CF 更常见治疗 <5 例(成人/IM,60%;儿科,40%;混合,29%)。转诊决策通常由年龄/诊断组合驱动(58%),常见 ALL 特定年龄下限(87%)或上限(80%)。医学、导航和社会工作服务在各个模型中相似,而心理学在更多儿科 CF 中可用(儿科,80%;成人/IM,40%;混合,46%-54%)。更多的儿科或混合 CF 报告肿瘤学家通过肿瘤委员会(儿科,93%;成人/IM,26%;混合,96%)或发起联系(儿科,100%;成人/IM,77%;混合,96%)与儿科/成人同行进行互动;更多的儿科 CF 报告有附属同行(儿科,53%;成人,19%)。大多数 CF 报告没有特定于 AYA 的资源(79%)或会议(83%-98%)。
以前尚未检查 AYA ALL 护理服务提供的系统层面方面。在 NCORP,这些特征按护理模式而有所不同。目前正在进行更多工作,以调查这些设施层面因素对该人群中符合指南的护理的影响。这些发现可以为不同实践环境提供系统层面的干预措施。